SpeeDx: Jeremy Stackawitz
SpeeDx has named Jeremy Stackawitz as its CEO, replacing Colin Denver. Stackawitz most recently served as CEO of Senzo Health, and previously held positions at AliveDx (formerly known as Quotient), McKinsey & Company, and Johnson & Johnson. He will focus on accelerating SpeeDx's commercialization, partnering, and regulatory activities across key markets, including the US.